Cardinal Health reports ‘outstanding first quarter’

DUBLIN, Ohio – Cardinal Health reported $64 billion in revenues for the first quarter of fiscal year 2026, a 22% increase from the same period in fiscal year 2025. 

Net earnings attributable to Cardinal Health were $450 million vs. $416 million, an 8% increase. 

"We are pleased with our strong broad-based operational and financial performance to begin fiscal 2026," said Jason Hollar, CEO of Cardinal Health. "This outstanding first quarter reflects our focused execution across each of our operating segments and provides a solid foundation as we carry forward. As a result, we are raising our fiscal 2026 outlook." 

For its Other segment, which includes Cardinal Health at-Home Solutions, the company reported revenue of $1.6 billion, a 38% increase year over year, and profit of $166 million, a 60% increase year over year. The company says these results were driven by growth across the three operating segments: at-Home Solutions (including the acquisition of Advanced Diabetes Supply), Nuclear and Precision Health Solutions and OptiFreight Logistics. 

Other financial results for the quarter: 

• First quarter GAAP operating earnings increased 18% to $668 million, and GAAP diluted earnings per share (EPS) increased 11% to $1.88. 
• First quarter non-GAAP operating earnings increased 37% to $857 million, driven by segment profit growth across all five of the company's operating segments. 
• Non-GAAP diluted EPS increased 36% to $2.55, reflecting the increase in non-GAAP operating earnings, a lower share count and a lower effective tax rate, partially offset by an increase in interest and other expense due to financing costs related to announced acquisitions. 

Cardinal is raising its guidance for: 

• Non-GAAP diluted EPS attributable to Cardinal Health, Inc. to a range of $9.65 to $9.85 (+17% to +20% growth). 
• Adjusted free cash flow to $3 billion to $3.5 billion, from a prior range of $2.75 billion to $3.25 billion. 

For the Other segment, the company now expects profit growth of 29% to 31%, from the prior range of 25% to 27%.